Adiponectin and development of type 2 diabetes in the Pima Indian population

Lancet

Volumn 360, Issue 9326, 2002, Pages 57-58

  Lindsay, Robert S ^a   Funahashi, Tohru ^b   Hanson, Robert L ^a   Matsuzawa, Yuji ^b   Tanaka, Sachiyo ^b   Tataranni, P Antonio ^a   Knowler, William C ^a   Krakoff, Jonathan ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INDIAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX;

EID: 0037031088     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09335-2     Document Type: Article

References (5)

1. A novel serum protein similar to C1q, produced exclusively in adipocytes
2. AdipoQ is a novel adipose-specific gene dysregulated in obesity
3. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
4. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
5. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity